Save 10% off your first order | Limited time offer | Create your account now

Downloads

COA COO

Physostigmine Salicylate

API

CAS Number

57-64-7

Molecular Formula

C15H21N3O2.C7H6O3

Product format

Neat

Molecular Weight

413.47

USP Description

Physostigmine Salicylate

EP Description

Physostigmine salicylate CRS

Storage

+5°C

Shipping

Room Temperature

API Family

Physostigmine

Synonyms

Physostigmine salicylate, (3aS, 8aR)-1, 2, 3, 3a, 8, 8a-hexahydro-1, 3a, 8-trimethylpyrrolo[2, 3-b]indol-5-yl methylcarbamate salicylate, Benzoic acid, 2-hydroxy-, compd. with (3aS, 8aR)-1, 2, 3, 3a, 8, 8a-hexahydro-1, 3a, 8-trimethylpyrrolo[2, 3-b]indol-5-yl methylcarbamate (1:1) (9CI), Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1, 2, 3, 3a, 8, 8a-hexahydro-1, 3a, 8-trimethylpyrrolo[2, 3-b]indol-5-yl methylcarbamate (1:1), Physostigmine salicylate (6CI), Physostigmine, monosalicylate (8CI), Pyrrolo[2, 3-b]indol-5-ol, 1, 2, 3, 3a, 8, 8a-hexahydro-1, 3a, 8-trimethyl-, methylcarbamate (ester), (3aS, 8aR)-, mono(2-hydroxybenzoate) (salt) (9CI), Pyrrolo[2, 3-b]indol-5-ol, 1, 2, 3, 3a, 8, 8a-hexahydro-1, 3a, 8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, mono(2-hydroxybenzoate) (salt), Salicylic acid, compd. with physostigmine (1:1) (8CI), (-)-Physostigmine salicylate, Eserine salicylate and Isopto Eserine

Smiles

CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1.OC(=O)c4ccccc4O

Iupac Name

[(3aR, 8bS)-3, 4, 8b-trimethyl-2, 3a-dihydro-1H-pyrrolo[2 and 3-b]indol-7-yl] N-methylcarbamate;2-hydroxybenzoic acid

Downloads

COA COO

Available products

Pack Size SKU
Category Expected Delivery Price Quantity

3-4 weeks

3-4 weeks

3-5 weeks

4-5 weeks

Request custom package size
Product added to your cart

Product Type

Custom
Synthesis

We offer tailor-made synthesis services of up to gram-quantities of materials for a wide range of pharmaceutical customers. The customer can order a specific molecule that is only synthesized on your request on the scale, with the purity and with the specification or methods you require.

Read more